SORIN GROUP: BOARD MEMBER'S CO-OPTATION

Milan, August 28th

, 2015 - Sorin S.p.A. announces that during a meeting held today, the Board of Directors coopted
Francesco Bianchi as member of the Board. As previously announced, Francesco Bianchi has also agreed
to serve on the Board of Directors of LivaNova PLC.
The Curriculum Vitae of Francesco Bianchi is available on the company's Internet site at the address
www.sorin.com.
About Sorin Group
Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of
cardiovascular diseases. The Company develops, manufactures and markets medical technologies for
cardiac surgery and for the treatment of cardiac rhythm disorders. With over 3,500 employees worldwide, the
Company focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open
heart surgery and heart valve repair or replacement products) and Cardiac Rhythm Management
(pacemakers, defibrillators, cardiac resynchronization devices). Every year, over one million patients are
treated with Sorin Group devices in more than 80 countries.
For more information, please refer to www.sorin.com or contact:
Gabriele Mazzoletti
Director, Corporate Communications
Sorin Group
Tel: +39 02 69969785
Mobile: +39 348 9792201
e-mail: corporate.communications@sorin.com
distributed by